Skip to Content
MilliporeSigma

SML4139

BCH-HSP-C01

≥98%

Synonym(s):

2-(1,4,6,7-Tetrahydro-5H-imidazo[4,5-c]pyridin-5-yl)benzo[d]thiazole, ATG9A Rectifier BCH-HSP-C01

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

Empirical Formula (Hill Notation):
C13H12N4S
CAS Number:
Molecular Weight:
256.33
NACRES:
NA.28
Assay:
≥98%
Form:
powder
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


Quality Segment

assay

≥98%

form

powder

color

white to beige

solubility

DMSO: 2 mg/mL, clear

storage temp.

2-8°C

SMILES string

C1(SC(N2CCC(NC=N3)=C3C2)=N4)=C4C=CC=C1

Biochem/physiol Actions

Restores ATG9A function and modulates intracellular trafficking and autophagy.


BCH-HSP-C01, a novel pharmacotherapeutic agent, is engineered to rectify ATG9A-related pathologies. Its primary mode of action entails the regulation of intracellular trafficking mechanisms, with a pronounced effect on the RAB protein family, integral to vesicular transport processes. Exhibiting both temporal and concentration-dependent characteristics, BCH-HSP-C01 optimally enhances ATG9A translocation within a 72–96 hour window post-administration, achieving an EC50 ~ 5 µM in hiPSC-derived neurons from AP-4-HSP patients. Furthermore, BCH-HSP-C01 markedly increases autophagic flux, as indicated by the elevated levels of LC3-II following its application and restores neuronal phenotypes of adapter protein complex 4 (AP-4)-deficiency.


Storage Class

11 - Combustible Solids

WGK

WGK 3

Flash Point (°F)

Not applicable

Flash Point (°C)

Not applicable



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library